Making a baby-maker

Investors give OvaScience cash to validate stem-cell driven IVF

Investors injected $37 million into OvaScience Inc. last week so the fertility company can produce clinical data proving its egg precursor stem cell technology can improve the success rate of in vitro fertilization. The

Read the full 343 word article

How to gain access

Continue reading with a
two-week free trial.